Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer (Q46681061)
Jump to navigation
Jump to search
scientific article published in September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer |
scientific article published in September 2005 |
Statements
1 reference
Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer (English)
1 reference
Alex A Adjei
1 reference
James R Jett
1 reference
Cynthia X Ma
1 reference
Suresh Nair
1 reference
Sachdev Thomas
1 reference
Sumithra J Mandrekar
1 reference
Daniel A Nikcevich
1 reference
Kendrith M Rowland
1 reference
Tom R Fitch
1 reference
Harold E Windschitl
1 reference
Shauna L Hillman
1 reference
Steven E Schild
1 reference
Coleman Obasaju
1 reference
North Central Cancer Treatment Group
1 reference
Mayo Clinic
1 reference
Eli Lilly & Company
1 reference
1 September 2005
1 reference
23
1 reference
25
1 reference
5929-5937
1 reference
Identifiers
1 reference